Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @AnimaBiotech
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @AnimaBiotech
-
Today marks the 20th anniversary of
#WorldCancerDay
! At Anima, we're proud to help advance #CancerResearch by working to discover small molecules that can inhibit the translation of the C-Myc#oncogene. Learn more: http://bit.ly/2RUNN1R pic.twitter.com/CrB39SCBp7
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Come see Co-founder & CEO Yochi Slonim present information about the various applications of our
#TranslationControlTherapeutics platform & join fellow experts for a panel discussion during the#LSXWorld Congress.@LSXLeaders For more info click here: http://bit.ly/2RUKhof pic.twitter.com/xJO4pMCgPZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#DYK fibrosis, or excessive connective tissue, caused by the over-production of Collagen Type I, can affect any organ? At Anima, we're developing compounds that are able to reduce the production of#collagen to prevent#fibrosis. Learn more here: http://bit.ly/38pJlNZ pic.twitter.com/qXE37lYb1a
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Take a look inside our
#TranslationControlTherapeutics screening platform to understand how we're able to use light pulses to find novel#SmallMolecules that regulate#mRNAtranslation selectively. Learn more here: http://bit.ly/2u86eH2#SeeTheLightpic.twitter.com/BrgRnoM48BHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Don't miss our CEO & co-founder Yochi Slonim's presentation today on our
#TranslationControlTherapeutics platform at@EBDGroup's#BiotechShowcase in#SF! For more information click here: http://bit.ly/2Rcht95 pic.twitter.com/Muqhj2UF6L
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#DYK Transfer RNA or#tRNA molecules are what interact with mRNA & bring the correct amino acid to the#ribosome, the translation machinery responsible for turning#mRNA into a protein? tRNA is at the core of our breakthrough biology platform. Learn more: http://bit.ly/36FlrNQ pic.twitter.com/fmw6h2lK6O
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ICYMI Our#website has a brand new look! Learn more about our#approach,#technology and#pipeline by checking it out for yourself here: http://bit.ly/2ZZpOkn#SeeTheLightpic.twitter.com/S1zuDdwR8o
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
At Anima, we're proud to be on the cutting edge of
#science & provide an innovative strategy to solve difficult-to-treat diseases with our#TranslationControlTherapeutics platform that broadens the scope of drug discovery. Read our media coverage here: http://bit.ly/2rFl6eV pic.twitter.com/wugHZddg5b
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#DYK not all#ribosomes are the same? There are many ribosome accessory proteins that help with#mRNA recognition & determine the rate of#ProteinSynthesis. At Anima, we're discovering new#SmallMolecules that target these regulatory proteins. Learn more: http://bit.ly/2ZpahtS pic.twitter.com/uUUNLnLs3v
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
At Anima, we're developing an internal
#pipeline across multiple therapeutic areas with high unmet need & hard to treat diseases. These include targeting#undruggable proteins C-Myc & Huntingtin with#SmallMolecule translation inhibitors. Learn more here: http://bit.ly/35QwQKD pic.twitter.com/3QQuhl38kj
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#DYK a disease is considered undruggable when it is difficult or impossible to develop a drug that targets proteins using known development methods? At Anima, our platform finds#SmallMolecules that can control protein synthesis#ondemand. Learn more: http://bit.ly/36BXJSr pic.twitter.com/g6OHHayeqn
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
At Anima, our
#TranslationControlTherapeutics platform generates millions of light pulse images enabling us to see how much of a target#protein is being made & gain new insights into disease biology by visually tracking#ProteinSynthesis. Learn more here: http://bit.ly/2slQX4a pic.twitter.com/D7FcTWQENl
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#DYK Cells have multiple mechanisms to regulate#mRNA transcripts?#RNA binding proteins are one type of RNA-modifying protein that are targeted by our small molecules to control#mRNAtranslation: http://bit.ly/2E0KsGG#TranslationControlTherapeuticspic.twitter.com/9fSNzeqVYX
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AnimaBiotech proslijedio/la je Tweet
We absolutely loved Yochi Slonim's (Co-Founder & CEO at
@AnimaBiotech) talk on 'Translation Control Therapeutics: Discovery of Small Molecule Drugs that Specifically Control mRNA Translation into Proteins' at this year's RNA Summit!pic.twitter.com/GskkAo1RmR
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our CEO & cofounder Yochi Slonim is excited to be in Boston to present our
#TranslationControlTherapeutics platform and join fellow experts for a panel discussion at the 2nd RNA-Targeted Drug Discovery Summit!@RNA_TDD Learn more here: http://bit.ly/2RiyPCN pic.twitter.com/umx4HnaeP5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Using our
#TranslationControlTherapeutics platform, we are bypassing traditional drug discovery methods to find & develop#SmallMolecule drugs that selectively control#mRNAtranslation. Learn more here: http://bit.ly/33FQebd pic.twitter.com/ZT5Xb4Kg9o
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're working to limit off target
#SideEffects of drugs by discovering#SmallMolecules that are#TissueSelective in their efficacy. Our approach is proven to find compounds selective in their activity and more versatile. Learn more: http://bit.ly/33l3VfD pic.twitter.com/I81SUsBSN6
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
At Anima Biotech, we're screening for
#SmallMolecule drugs that can decrease or increase the production of target proteins#OnDemand. Learn more about how we do this here: http://bit.ly/33otxbc pic.twitter.com/oQ4DLRhKNX
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Interested in learning more about our scientific collaborations? At Anima, we've performed ground-breaking
#research with#scientists at@scrippsresearch,@OxfordPhysics &@DukeU. Check out the research articles from those collaborations here: http://bit.ly/2pCOv8v pic.twitter.com/e30Dml03aW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
This week we’re excited to announce our CEO and cofounder Yochi Slonim is presenting our
#TranslationControlTherapeutics technology at the 6th China Healthcare Summit hosted by@BioCentury & BayHelix in Shanghai. Learn more about our platform here: http://bit.ly/37g50Z4 pic.twitter.com/yyk9DtsZ1i
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.